VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CCMConcord Medical Services Holdings Limited
$5.35$779040
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCCMEarnings History

CCM logoConcord Medical Services Holdings Limited (CCM) Earnings History

Net Loss

17 years of earnings data (2008–2024) · Currently unprofitable on a TTM basis

TTM Net Income
-$163M
● Net Loss
TTM EPS (Diluted)
$-1120.21
Per share, diluted
YoY EPS Growth
-3.6%
Slow
Net Margin
-80.3%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin-138.6%
Gross Margin-20.6%
Return on Equity-18.3%
Return on Assets-4.8%
Record Annual Net Income$129MFY2010
Record Quarterly EPS$69.90Q4 2013
Consecutive Profitable Years0years
Q2 2025
Net Income-$14M
EPS (Diluted)$-94.50
YoY Growth-3.6%Slow
QoQ Growth+0.0%Solid

Loading earnings history...

Concord Medical Services Holdings Limited (CCM) Earnings Overview

As of June 23, 2026, Concord Medical Services Holdings Limited (CCM) reported trailing twelve-month net income of -$163M, reflecting -3.6% year-over-year growth. The company earned $-1120.21 per diluted share over the past four quarters, with a net profit margin of -80.3%.

Looking at the long-term picture, CCM's historical earnings data spans multiple years. The company achieved its highest annual net income of $129M in fiscal 2010.

Concord Medical Services Holdings Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including RDNT (-$14M net income, -0.9% margin), USPH ($11M net income, 1.9% margin), AMSF ($46M net income, 14.9% margin), CCM has room to improve margins relative to the peer group. Compare CCM vs RDNT →

CCM Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
CCM logoCCMCurrent
-$163M$-1120.21-80.3%-18.3%-3.6%—
RDNT logoRDNT
-$14M$-0.18-0.9%-1.5%-768.4%
USPH logoUSPH
$11M$0.701.9%2.0%-22.8%
AMSF logoAMSF
$46M$2.4614.9%18.5%-14.5%
ARAY logoARAY
-$46M$-0.37-0.3%-2.5%+90.3%
MLAB logoMLAB
$7M$1.212.7%3.9%+436.1%
Best in group
Lowest in group

CCM Historical Earnings Data (2008–2024)

17 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2024-$308M-3.6%-$532M$-2116.80-80.3%-138.6%
2023-$298M+39.2%-$463M$-2044.20-55.4%-86.2%
2022-$490M-80.4%-$525M$-3362.70-103.7%-111.2%
2021-$271M+12.4%-$458M$-5635.50-55.9%-94.4%
2020-$310M-1.0%-$316M$-4600.50-139.0%-141.7%
2019-$307M-30.7%-$437M$-3818.10-154.8%-220.5%
2018-$235M+17.4%-$299M$-2484.90-123.0%-156.8%
2017-$284M-8.6%-$212M$-1967.10-85.9%-64.0%
2016-$262M-234.4%-$169M$-1804.20-57.5%-37.1%
2015-$78M-162.8%-$6M$-523.80-12.7%-0.9%
2014$125M+45.2%$184M$658.5020.5%30.3%
2013$86M-30.3%$156M$500.7015.3%27.8%
2012$123M+157.3%$184M$80.1027.0%40.4%
2011-$215M-266.2%$139M$-45.30-47.8%30.8%
2010$129M+3.7%$180M$26.7033.2%46.1%
2009$125M+57.9%$167M$55.8042.7%57.2%
2008$79M-$102M$41.4046.0%59.3%

Download Data

Export CCM earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

18+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CCM — Frequently Asked Questions

Quick answers to the most common questions about buying CCM stock.

What is CCM earnings per share (EPS)?

CCM trailing twelve-month (TTM) diluted EPS is $-1120.21, reflecting -3.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2008 to 2024 is available in the table on this page.

What is Concord Medical Services Holdings Limited's net income?

Concord Medical Services Holdings Limited (CCM) trailing twelve-month net income is $-163M as of 2024. Earnings declined -3.6% year-over-year.

Is CCM profitable?

CCM is not currently profitable on a TTM basis, reporting a net loss of $-163M. Net margin is -80.3%. Investors should monitor for a return to profitability.

What is CCM's earnings growth rate?

CCM compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2008 to 2024.

What are CCM's profit margins?

Concord Medical Services Holdings Limited net profit margin is -80.3%, operating margin is -138.6%, and gross margin is -20.6%. Below-average margins reflect competitive or cost pressures. Return on Equity is -18.3%.

Is CCM growing earnings?

CCM earnings growth is slowing. Current YoY EPS growth of -3.6% trails the 5-year CAGR of N/A. TTM net income is $-163M.

What was CCM's best earnings year?

Concord Medical Services Holdings Limited's highest annual net income on record is $129M, achieved in fiscal year 2010. Earnings history on this page spans 2008 to 2024 and includes all annual and quarterly figures.

What were CCM's earnings last quarter?

CCM's most recent reported quarter was Q2 2025. Net income was $-14M with diluted EPS of $-94.50. For a full breakdown of all quarters, see the quarterly earnings table on this page.

CCM Earnings Over Time (2008–2024)

Net income & EPS — annual and quarterly view